ArticleAnnals of intensive care2026
Health-related quality of life trajectories one year after COVID-19-induced ARDS: A secondary analysis of the CONFIDENT trial.
Article in Annals of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04558476 (A Multicenter Randomized Trial to Assess the Efficacy of CONvalescent Plasma Therapy in Patients With Invasive COVID-19 and Acute Respiratory Failure Treated With Mechanical Ventilation), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Multicenter Randomized Trial to Assess the Efficacy of CONvalescent Plasma Therapy in Patients With Invasive COVID-19 and Acute Respiratory Failure Treated With Mechanical Ventilation: the CONFIDENT Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale: Survivors of ARDS are at risk of persistent physical and psychological impairments, yet reliable prognostic factors for long-term recovery are poorly defined. The aims of the study were to describe changes in health-related quality of life (HRQoL) during the year after discharge from intensive care unit (ICU) in a cohort of ARDS survivors, and to identify factors associated with a favorable recovery trajectory. Methods: This planned secondary analysis used prospectively collected data from the multicenter randomized CONFIDENT trial that enrolled 475 mechanically ventilated COVID-19 ARDS patients. Patients who completed interviews at both day 90 (D90) and one year (Y1) were included. HRQoL was assessed using the EQ-5D-5L utility score (EQ-score) and visual analog scale (EQ-VAS). Baseline status, disease severity, and ICU characteristics were analyzed for associations with HRQoL changes. Results: 156 survivors completed follow-up at both D90 and Y1. EQ-score and EQ-VAS significantly improved between D90 and Y1 (p < 0.0001 and p = 0.0002 respectively), but both remained lower than pre-ICU status. Notably, 38 and 43% of patients showed stagnation or deterioration in EQ-score and EQ-VAS over the year. Longer durations of mechanical ventilation, ICU stay, and hospital stay were associated with greater EQ-score and EQ-VAS recovery, whereas shorter stays were linked to less improvement (respectively p = 0.0002 and p = 0.025, p = 0.0002 and p = 0.0035, p = 0.0020 and p = 0.026). Demographics and pre-admission frailty showed no impact on the recovery trajectory. Conclusion: In this multicenter cohort of ARDS survivors, patients with shorter durations of mechanical ventilation, ICU and hospital stay experienced poorer HRQoL recovery, independently of baseline characteristics such as age or frailty. Trial registration: Clinicaltrials.gov registration number NCT04558476. Registered 14 September 2020-Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT04558476.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.